ATRC
AtriCure, Inc.+$0.53 (0.89%) At close $60.41 · Today
☾After Hours −$1.81 (3.00%) Nov 3, 7:59 PM ET
About ATRC
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Company
- Headquarters
- Mason, OH
- Employees
- 1,350 (2026)
- Listed
- Aug 5, 2005
- Exchange
- Nasdaq
- Website
- atricure.com
- SEC industry
- Surgical & Medical Instruments & Apparatus
- Cylvex sector
- Health Care · Medical Devices
Medical Devices
- Market cap #36 of 163
- P/B #43 of 152
Ranked highest first among stocks Cylvex covers.
- ABTAbbott Laboratories$189.3B-0.69%
- ISRGIntuitive Surgical Inc$155.7B+0.89%
- MDTMedtronic plc$126.5B-0.41%
- SYKStryker Corporation$119.1B+1.22%
- BSXBoston Scientific Corp.$63.04B-1.85%
Financial summary
Related companies
About
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
From company filings and market data · Not investment advice
Price data
52W range and average volume from daily bars (unadjusted, last 252 sessions).
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.